Hacks at the Wall Street Journal have landed a cracking new line on the Qiagen takeover story that has been rumbling around European markets for the last two years.
According to the WSJ, US-listed medical diagnostics group Bio-Rad Laboratories Inc is in merger talks with Qiagen, which had previously been in negotiations France's BioMerieux about a combination.
Below is the link to the WSJ story:..
I see rivals at CTFN are pissing from a high height all over little old Betaville's RARE ALERT from yesterday about An American company, possibly Thermo Fisher Scientific, weighing a counter approach for Qiagen, the US-European listed diagnostics group. Below is a link to the CTFN tale:
https://ctfn.news/news/nov-17-2021-qgen-548755..
Another day, another follow up from arch rivals at Bloomberg.
This time Bloomie hacks have picked up on little old Betaville's UNCOOKED Alert series about Qiagen, the Frankfurt and Nasdaq-listed molecular testing firm, from last week.
Now Bloomberg is reporting that French diagnositics firm BioMeurieux is in talks with Qiagen about a mutli-billion EURO merger. Below is the link:..
There are a few pieces out this week from Bloomberg about how recent market turbulence is starting to hit dealmaking.
But it's still pretty lively in the pharmaceutical and healthcare industries. Take, for example, this week's announcement from US giant Thermo Fisher about its $11.5 billion acquisition of Qiagen, the Dutch diagnostics testing group...